Table 3.
Values obtained during visit 3 (pre 2) and visit 6 (48 h post) for the indirect markers of EIMD tests and the MIE tests completed for CON and EXP (n = 50).
| Measure | CON (n = 10) | EXP (n = 40) | ||||||
|---|---|---|---|---|---|---|---|---|
| Visit 3 | Visit 6 | Mean diff | 95% CI | Visit 3 | Visit 6 | Mean diff | 95% CI | |
| EIPmax [median,(min – max)] | 2 (0–3) | 1 (0–3) | 0 | −1.3, 0.8 | 2 (0–4) | 4 (0–7)a+b | 2 | 1.4, 2.5 |
| TTE (s) | 997 (90) | 1003 (83) | 6 | −18.4, 31.4 | 997 (94) | 964 (98)a+b | −34 | −45.2, −19.7 |
| Soreness (mm) | 8 (5) | 11 (14) | 3 | −18, 10 | 11 (12) | 62 (21)a+b | 51 | 44, 58 |
| CK (IU/L) | 112 (44) | 116 (109) | 4 | −132, 142 | 116 (80) | 227 (131)a+b | 111 | 42, 179 |
| MVC dom (N.m) | 158 (68) | 157 (60) | −1 | −9, 11 | 156 (42) | 142 (49)a+b | −14 | −19, −9 |
| MVC non−dom (N.m) | 153 (62) | 145 (59) | −8 | −19, 3 | 145 (42) | 131 (44)a+b | −14 | −19, −8 |
| VA dom (%) | 85 (9) | 86 (8) | 1 | −8, 5 | 86 (8) | 81 (13)a+b | −5 | −8, −2 |
| VA non-dom (%) | 88 (7) | 86 (8) | −2 | −6, 8 | 83 (9) | 78 (11)a+b | −5 | −9, −2 |
| (L·min−1) | 3.20 (0.84) | 3.07 (0.77) | −0.13 | −0.41, 0.16 | 3.08 (0.74) | 3.00 (0.77) | −0.09 | −0.21, 0.04 |
| (L·min−1) | 3.73 (0.98) | 3.82 (0.98) | 0.09 | −0.31, 0.48 | 3.53 (0.57) | 3.43 (0.54) | −0.09 | −0.89, 0.10 |
| (L·min−1) | 120 (34) | 118 (35) | −2 | −13.5, 8.4 | 107 (24) | 108 (25) | 1 | −6.0, 4.7 |
| VT (km·h·−1) | 11.1 (1.0) | 10.9 (0.8) | −0.2 | −2.2, 1.7 | 11.2 (1.7) | 11.0 (1.5) | −0.2 | −1.1, 0.7 |
| HRmax (b·min−1) | 194 (7) | 194 (7) | 0 | −4.2, 4.7 | 195 (9) | 190 (11)a+b | −5 | −6.8, −2.4 |
| BLamax (mmol/L) | 12.3 (3.2) | 12.2 (3.5) | −0.1 | −1.5, 1.3 | 10.5 (2.9) | 9.6 (2.7)a+b | −0.9 | −1.6, −0.2 |
| RERmax | 1.17 (0.06) | 1.21(0.07) | 0.04 | −0.01, 0.08 | 1.16 (0.07) | 1.16 (0.08) | 0 | −0.03, 0.02 |
| RPEmax [median,(min – max)] | 19 (17–20) | 19 (17–19) | 0 | −0.3, 0.2 | 19 (17–20) | 19 (17–20) | 0 | −0.1, 0.3 |
Values are reported as mean (SD) unless otherwise specified.
a+b
significant interaction effect (group x trial). MIE, maximal incremental exercise; EIMD, exercise induced muscle damage; CON, control; EXP, experimental. See footnote of Table 1 for definitions of the abbreviations and lettering not listed.